GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010.

Business Wire (November 16, 2009)

Linked as:

Extract

GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010.

LONDON & RESEARCH TRIANGLE PARK, N.C. & SANTA CLARA, Calif. -- In BW 5972 issued November 6, 2009: First graph, second sentence of release (dated November 6, 2009) should read: The NDA currently under review by the FDA is ...

See the full content of this document